Blue Water Life Science Advisors, LP Guardant Health, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $103 Million
- Q2 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 571,047 shares of GH stock, worth $13.1 Million. This represents 16.04% of its overall portfolio holdings.
Number of Shares
571,047
Previous 571,047
-0.0%
Holding current value
$13.1 Million
Previous $11.8 Million
39.99%
% of portfolio
16.04%
Previous 11.08%
Shares
12 transactions
Others Institutions Holding GH
# of Institutions
330Shares Held
113MCall Options Held
680KPut Options Held
1.66M-
Vanguard Group Inc Valley Forge, PA11.6MShares$268 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$258 Million0.01% of portfolio
-
Baillie Gifford & CO6.09MShares$140 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$104 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$103 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.35B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...